NCT04557449
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04557449
Title Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (CDK4i)
Acronym CDK4i
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SVK | GBR | CZE | ARG

Facility Status City State Zip Country Details
Ellison Institute Los Angeles California 90064 United States Details
Smilow Cancer Hospital at Yale - New Haven New Haven Connecticut 06510 United States Details
Yale-New Haven Hospital-Yale Cancer Center New Haven Connecticut 06510 United States Details
Smilow Cancer Hospital Phase 1 Unit New Haven Connecticut 06511 United States Details
Brigham & Women's Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute- Chestnut Hill Newton Massachusetts 02459 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Sarah Cannon Research Institute - Pharmacy Nashville Tennessee 37203 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Hospital Británico de Buenos Aires Ciudad Autónoma de Buenos Aires Buenos Aires 1280 Argentina Details
Fundación Cenit Para La Investigación En Neurociencias CABA Ciudad Autã³noma de Buenos Aires 1125 Argentina Details
Fundación Respirar Buenos Aires C1426ABP Argentina Details
Clínica Universitaria Reina Fabiola Córdoba X50004FHP Argentina Details
Fundación CORI para la Investigación y Prevención del Cáncer La Rioja F5300COE Argentina Details
Cancer Hospital Chinese Academy of Medical Science Beijing Beijing Municipality 100021 China Details
Henan Cancer Hospital Zhengzhou Henan 450008 China Details
Hubei Cancer Hospital Wuhan Hubei 430079 China Details
The First Affiliated Hospital of Xi'an Jiaotong University Xi’an Shanxi 710061 China Details
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang 310016 China Details
Fakultni nemocnice Olomouc Olomouc 779 00 Czechia Details
Vseobecna fakultni nemocnice v Praze Prague 12808 Czechia Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
Hospital MAC Periferico Sur Mexico City Mexico City 04700 Mexico Details
INCAN Mexico City Mexico City 14080 Mexico Details
COI Centro Oncologico Internacional S.A.P.I. de C.V. Mexico City Mexico City Mexico Details
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" Monterrey Nuevo León 64460 Mexico Details
Hospital Reforma Oaxaca City Oaxaca 68000 Mexico Details
Oaxaca Site Management Organization Oaxaca City 68000 Mexico Details
Onkologicky ustav sv. Alzbety, s.r.o., Interna klinika VSZaSP a OUSA Bratislava 812 50 Slovakia Details
Narodny onkologicky ustav Bratislava 833 10 Slovakia Details
Fakultna nemocnica s poliklinikou Nove Zamky Nové Zámky 940 34 Slovakia Details
POKO Poprad, s.r.o. Poprad 058 01 Slovakia Details
Cancer Research UK Edinburgh Centre Edinburgh Edinburgh, CITY of EH4 2XR United Kingdom Details
St Bartholomew's Hospital London London, CITY of EC1A 7BE United Kingdom Details
Sarah Cannon Research Institute UK London W1G 6AD United Kingdom Details
The Christie Hospital NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field